42 related articles for article (PubMed ID: 12407696)
1. Morphological and molecular basis of ovarian serous carcinoma.
Rosen DG; Zhang Z; Shan W; Liu J
J Biomed Res; 2010 Jul; 24(4):257-63. PubMed ID: 23554638
[TBL] [Abstract][Full Text] [Related]
2. Genome profiling of ovarian adenocarcinomas using pangenomic BACs microarray comparative genomic hybridization.
Caserta D; Benkhalifa M; Baldi M; Fiorentino F; Qumsiyeh M; Moscarini M
Mol Cytogenet; 2008 May; 1():10. PubMed ID: 18492273
[TBL] [Abstract][Full Text] [Related]
3. The human ovarian teratocarcinoma cell line PA-1 demonstrates a single translocation: analysis with fluorescence in situ hybridization, spectral karyotyping, and bacterial artificial chromosome microarray.
Sarraf S; Tejada R; Abawi M; Oberst M; Dennis T; Simon KC; Blancato J
Cancer Genet Cytogenet; 2005 Aug; 161(1):63-9. PubMed ID: 16080959
[TBL] [Abstract][Full Text] [Related]
4. Methodologies in cancer cytogenetics and molecular cytogenetics.
Wang N
Am J Med Genet; 2002 Oct; 115(3):118-24. PubMed ID: 12407691
[TBL] [Abstract][Full Text] [Related]
5. Chromosome 6 abnormalities in ovarian surface epithelial tumors of borderline malignancy suggest a genetic continuum in the progression model of ovarian neoplasms.
Tibiletti MG; Bernasconi B; Furlan D; Bressan P; Cerutti R; Facco C; Franchi M; Riva C; Cinquetti R; Capella C; Taramelli R
Clin Cancer Res; 2001 Nov; 7(11):3404-9. PubMed ID: 11705855
[TBL] [Abstract][Full Text] [Related]
6. Parallel analysis of sporadic primary ovarian carcinomas by spectral karyotyping, comparative genomic hybridization, and expression microarrays.
Bayani J; Brenton JD; Macgregor PF; Beheshti B; Albert M; Nallainathan D; Karaskova J; Rosen B; Murphy J; Laframboise S; Zanke B; Squire JA
Cancer Res; 2002 Jun; 62(12):3466-76. PubMed ID: 12067990
[TBL] [Abstract][Full Text] [Related]
7. [Oncogene ZNF217 amplification on chromosome 20 q in ovarian serous cystadenocarcinoma and its clinical implications].
Li J; Zhong M; Song LL; Su GD
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):824-5. PubMed ID: 16793610
[TBL] [Abstract][Full Text] [Related]
8. Cytogenetics and molecular genetics of ovarian cancer.
Wang N
Am J Med Genet; 2002 Oct; 115(3):157-63. PubMed ID: 12407696
[TBL] [Abstract][Full Text] [Related]
9. The role of protein elongation factor eEF1A2 in ovarian cancer.
Lee JM
Reprod Biol Endocrinol; 2003 Oct; 1():69. PubMed ID: 14588074
[TBL] [Abstract][Full Text] [Related]
10. Clinical and molecular cytogenetics and gene mapping: principles and techniques.
Francke U
Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():34-43. PubMed ID: 8629138
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in cancer cytogenetics.
Trent JM
Ariz Med; 1981 Nov; 38(11):836-9. PubMed ID: 7032475
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
